1a9m | G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR U-89360E |
1ajv | HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006 |
1ajx | HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001 |
1axa | ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT |
1bqm | HIV-1 RT/HBY 097 |
1bqn | TYR 188 LEU HIV-1 RT/HBY 097 |
1d4h | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435 |
1d4i | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425 |
1d4j | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370 |
1dlo | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
1dw6 | STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE |
1ebk | STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE |
1ebw | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322 |
1eby | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369 |
1ebz | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388 |
1ec0 | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403 |
1ec1 | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409 |
1ec2 | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428 |
1ec3 | HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367 |
1eet | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204 |
1har | HIV-1 REVERSE TRANSCRIPTASE (AMINO-TERMINAL HALF) (FINGERS AND PALM SUBDOMAINS) (RT216) |
1hbv | HIV-1 PROTEASE COMPLEXED WITH SB203238 |
1hef | HIV-1 PROTEASE COMPLEXED WITH SKF 108738 (HEF) |
1heg | HIV-1 PROTEASE COMPLEXED WITH SKF 107457 (HEG) |
1hih | HIV-1 PROTEASE COMPLEXED WITH INHIBITOR CGP 53820 |
1hmv | HIV-1 REVERSE TRANSCRIPTASE |
1hni | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (HIV-1RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S) |
1hnv | HIV-1 REVERSE TRANSCRIPTASE (HIV-1 RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S) |
1hos | HIV-1 PROTEASE COMPLEX WITH SB204144 |
1hps | HIV-1 PROTEASE COMPLEXED WITH SB206343 |
1hpz | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
1hqe | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
1hqu | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
1hrh | RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE |
1hte | HIV-1 PROTEASE COMPLEXED WITH GR123976 |
1htf | HIV-1 PROTEASE COMPLEXED WITH GR126045 |
1htg | HIV-1 PROTEASE COMPLEXED WITH GR137615 |
1hvk | HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR A76928 (S, S) |
1hvp | HIV-1 PROTEASE COMPLEX WITH SUBSTRATE (THEORETICAL MODEL) |
1hvu | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RIBONUCLEIC ACID PSEUDOKNOT |
1hys | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH A POLYPURINE TRACT RNA:DNA |
1ikv | K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFIVARENZ |
1ikw | WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFAVIRENZ |
1ikx | K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHTHE INHIBITOR PNU142721 |
1iky | HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITORMSC194 |
1j5o | CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSETRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER |
1mer | HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450 |
1mes | HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 |
1met | HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323 |
1meu | HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323 |
1n5y | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P) |
1n6q | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N) |
1npa | CRYSTAL STRUCTURE OF HIV-1 PROTEASE-HUP |
1npv | CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LDC271 |
1npw | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH LGZ479 |
1qe1 | CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV -1 REVERSE TRANSCRIPTASE |
1qmc | C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES |
1r0a | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLYTETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2. 8 ANGSTROMS |
1rdh | HIV-1 REVERSE TRANSCRIPTASE (RIBONUCLEASE H DOMAIN) |
1rtd | STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE |
1rvl | REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH ALPHA-APA (R89439) (THEORETICAL MODEL) |
1rvm | REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH HEPT (THEORETICAL MODEL) |
1rvn | REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH PHENYL-ISOINDOLINONE (THEORETICAL MODEL) |
1rvo | REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH NEVIRAPINE (THEORETICAL MODEL) |
1rvp | REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH THIAZOLOISOINDOLINONE (THEORETICAL MODEL) |
1rvq | REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH TIBO (THEORETICAL MODEL) |
1rvr | REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH IMIDAZODIPYRIDODIAZEPINE (UK-129,485) ( THEORETICAL MODEL) |
1s6p | CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN- R100943 |
1s6q | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN-R147681 |
1s9e | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN-R129385 |
1s9g | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN-R120394. |
1sbg | HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR SB203386 |
1suq | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN-R185545 |
1sv5 | CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSETRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335 |
1t03 | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIRTERMINATED TEMPLATE-PRIMER (COMPLEX P) |
1t05 | HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE- PRIMERWITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE |
1t7k | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITHARYLSULFONAMIDE AZACYCLIC UREA |
1tv6 | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707 |
1tvr | HIV-1 RT/9-CL TIBO |
1uwb | TYR 181 CYS HIV-1 RT/8-CL TIBO |
1w5v | HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL -BASED C2-SYMMETRIC INHIBITOR |
1w5w | HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL -BASED C2-SYMMETRIC INHIBITOR |
1w5x | HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL -BASED C2-SYMMETRIC INHIBITOR |
1w5y | HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL -BASED C2-SYMMETRIC INHIBITOR |
1yt9 | HIV PROTEASE WITH OXIMINOARYLSULFONAMIDE BOUND |
2b5j | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN-R165481 |
2b6a | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH THR-50 |
2ban | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN-R157208 |
2bbb | STRUCTURE OF HIV1 PROTEASE AND HH1_173_3A COMPLEX. |
2be2 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH R221239 |
2hmi | HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE- STRANDED DEOXYRIBONUCLEIC ACID AND FAB28 |
2uxz | TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC |
2uy0 | TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC |
2vg5 | CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS |
2vg6 | CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS |
2vg7 | CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS |
2x4u | CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE RT468-476 |
2xye | HIV-1 INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC AND VARIOUS P2 AND P1 PRIME SUBSTITUENTS |
2xyf | HIV-1 INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC AND VARIOUS P2 AND P1 PRIME SUBSTITUENTS |
2ykm | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI) |
3hvt | REVERSE TRANSCRIPTASE |
3tlh | STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR |